Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Kamada Ltd (KMDA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 217,404
  • Shares Outstanding, K 40,260
  • Annual Sales, $ 102,830 K
  • Annual Income, $ 6,900 K
  • 36-Month Beta 1.22
  • Price/Sales 2.15
  • Price/Cash Flow 21.28
  • Price/Book 2.31

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/18
See More
  • Average Estimate 0.02
  • Number of Estimates 2
  • High Estimate 0.06
  • Low Estimate -0.02
  • Prior Year -0.01
  • Growth Rate Est. (year over year) +300.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.80 +13.54%
on 08/10/18
6.10 -10.66%
on 07/20/18
-0.15 (-2.68%)
since 07/17/18
3-Month
4.78 +14.14%
on 05/29/18
6.10 -10.66%
on 07/20/18
+0.60 (+12.37%)
since 05/17/18
52-Week
4.15 +31.33%
on 08/29/17
6.10 -10.66%
on 07/20/18
+1.00 (+22.47%)
since 08/17/17

Most Recent Stories

More News
The Zacks Analyst Blog Highlights: American River, BG Staffing, Evolution Petroleum, Kamada and Farmers & Merchants

The Zacks Analyst Blog Highlights: American River, BG Staffing, Evolution Petroleum, Kamada and Farmers & Merchants

AMRB : 15.60 (unch)
EPM : 9.90 (-0.50%)
FMAO : 43.88 (-1.90%)
BGSF : 29.07 (+2.25%)
KMDA : 5.45 (+0.93%)
Dollar Strengthens on Turkey's Trouble: Top 5 Gainers

Lira loses more than 20% over the week as international markets react to the uncertainty over Turkey's capability to repay foreign-currency debts. Dollar hits a one-year high.

AMRB : 15.60 (unch)
EPM : 9.90 (-0.50%)
FMAO : 43.88 (-1.90%)
BGSF : 29.07 (+2.25%)
KMDA : 5.45 (+0.93%)
Kamada (KMDA) Surpasses Q2 Earnings and Revenue Estimates

Kamada (KMDA) delivered earnings and revenue surprises of 55.56% and 14.20%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?

KMDA : 5.45 (+0.93%)
Kamada Reports Financial Results for Second Quarter and First Six Months of 2018

-- Total Revenues for First Half of 2018 were $51.3 Million, a 16% Increase Over First Half of 2017

KMDA : 5.45 (+0.93%)
Kamada to Announce Second Quarter and Six Months Ended June 30, 2018 Financial Results and Host Conference Call on August 7

Kamada Ltd. (NASDAQ & TASE: KMDA), a plasma-derived protein therapeutics company, today announced that it will release financial results for the quarter and six months ended June 30, 2018, prior to the...

KMDA : 5.45 (+0.93%)
Kamada Receives Positive Scientific Advice from European Medicines Agency on a New Phase 3 Study Design for Inhaled AAT

Kamada Ltd. (the "Company") (NASDAQ:KMDA) (TASE:KMDA), a plasma-derived protein therapeutics company, today announced that it has received positive scientific advice from the Committee for Medicinal Products...

KMDA : 5.45 (+0.93%)
Is Kamada (KMDA) Outperforming Other Medical Stocks This Year?

Is (KMDA) Outperforming Other Medical Stocks This Year?

KMDA : 5.45 (+0.93%)
4 Undervalued MedTech Stocks to Consider Amid Volatility

Amid turbulences of the U.S. market, some value stocks of MedTech industry appear to be lucrative investment options.

ANIP : 56.41 (+1.06%)
CRHM : 3.95 (+4.50%)
CPSI : 27.10 (-0.73%)
KMDA : 5.45 (+0.93%)
5 Biotech Stocks Under $10 Worthy of Investors' Attention

Small biotech stocks are good bets with lower market cap as well as share price.

MNLO : 7.71 (-2.53%)
SHPG : 170.42 (-0.63%)
CYTR : 1.10 (+2.80%)
KMDA : 5.45 (+0.93%)
BLPH : 0.79 (+21.54%)
SNSS : 1.95 (-5.34%)
SNY : 42.04 (+1.92%)
Results of Kamada's Phase 2 Trial of Alpha-1 Antitrypsin in Newly Diagnosed Type-1 Diabetes Patients to be Presented at the Upcoming American Diabetes Association's 78th Scientific Sessions

Kamada Ltd. (Nasdaq:KMDA) (TASE:KMDA), a plasma-derived protein therapeutics company, today announced that the results from the Company's Phase 2 trial of Alpha-1 Antitrypsin (AAT) in newly diagnosed type-1...

KMDA : 5.45 (+0.93%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

See More Share

Trade KMDA with:

Business Summary

Kamada Ltd. is a biopharmaceutical company. It develops, produces and markets therapeutics based on chromatographic purification technology. The company offers bio-therapeutics for specialty proteins, specific immunoglobulins and other prescription medicines. Kamada Ltd. is headquartered in Ness Ziona,...

See More

Key Turning Points

2nd Resistance Point 5.58
1st Resistance Point 5.52
Last Price 5.45
1st Support Level 5.37
2nd Support Level 5.28

See More

52-Week High 6.10
Last Price 5.45
Fibonacci 61.8% 5.36
Fibonacci 50% 5.13
Fibonacci 38.2% 4.89
52-Week Low 4.15

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar